Skip to main content
IDWeek 2021 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
View Session ViewAttendees 27

Epidemiology & Infection Control

Global ID

Investigative ID

Pediatric ID

Trainee

COVID
Symposium

69 - Emergence of a new SARS-CoV-2 critical illness: what is it and how do we treat it

Friday, October 1, 2021
10:00 AM - 11:15 AM EDT

    Moderator(s)

  • Kristina Bryant, MD, FPIDS

    Professor of Pediatrics
    University of Louisville and Norton Children's
    Louisville, KY, United States

    Gilead (Individual(s) Involved: Self): Grant/Research Support; Pfizer (Individual(s) Involved: Self): Grant/Research Support

  • Delane Shingadia, MBChB, FRCPCH

    Consultant
    Great Ormond Street Hospital
    London, England, United Kingdom

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

    • Speaker(s)

  • Michael Levin, MBE PhD FMedSci

    Professor of Paediatrics and Child Health
    Imperial College London

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

  • Adriana Tremoulet, MD

    Professor
    University of California San Diego
    San Diego, CA, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

Participants should be aware of the following financial/non-financial relationships:
Kristina Bryant, MD, FPIDS: Gilead (Individual(s) Involved: Self): Grant/Research Support; Pfizer (Individual(s) Involved: Self): Grant/Research Support
Delane Shingadia, MBChB, FRCPCH: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Michael Levin, MBE PhD FMedSci: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Adriana Tremoulet, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
ACPE Credits: ACPE 1.25 contact hours of pharmacy CE
ACPE Number:

Learning Objectives:

At the conclusion of this session, participants will be able to:
  • compare and contrast the clinical, epidemiological, and laboratory similarities and differences among children and adolescents with the post-infectious inflammatory syndromes MIS-C and PIMS-TS in the United Kingdom and the United States
  • compare and contrast the short-and-long term management of children and adolescents with MIS-C and PIMS-TS in the United Kingdom and the United States
  • discuss the challenges associated with applying the surveillance definitions for PIMS-TS/ MIS-C, Kawasaki Disease, and Toxic Shock Syndrome, to children and adolescents presenting with inflammatory conditions during the COVID-19 pandemic

Presentations:

  • Clinical presentation and novel diagnostic test development for Multisystem Inflammatory Syndrome in Children

    Speaker: Adriana Tremoulet, MD – University of California San Diego

    Speaker: Elizabeth Whittaker, MD

  • Therapeutic Investigation for Multisystem Inflammatory Syndrome in Children

    Speaker: Adriana Tremoulet, MD – University of California San Diego

    Speaker: Elizabeth Whittaker, MD